Application 077699
- Type
- ANDA
- Sponsor
- HIKMA INTL PHARMS
Application Products#
| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|---|---|---|---|---|---|
| 001 | MEFLOQUINE HYDROCHLORIDE | MEFLOQUINE HYDROCHLORIDE | TABLET;ORAL | 250MG | No | No |
Orange Book products#
| Application-product | Trade name | Ingredient | Strength | Dosage form / route | TE codes | RLD / RS | Approval date |
|---|---|---|---|---|---|---|---|
| A077699-001 | MEFLOQUINE HYDROCHLORIDE | MEFLOQUINE HYDROCHLORIDE | 250MG | TABLET / ORAL | 2010-04-21 |
Observed Orange Book product history#
Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
| Captured | Edition | Application-product | Trade name | Strength | Dosage form / route | Product TE source text | RLD / RS | Approval date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|---|
| 2022-10-28 04:53 UTC | 2022-10 | A077699-001 | MEFLOQUINE HYDROCHLORIDE | 250MG | TABLET / ORAL | 2010-04-21 | f41ea6bd6efb… | ||
| 2022-09-29 23:25 UTC | 2022-09 | A077699-001 | MEFLOQUINE HYDROCHLORIDE | 250MG | TABLET / ORAL | 2010-04-21 | e64feba35796… | ||
| 2022-07-09 03:26 UTC · 3 captures of this ZIP | 2022-07 | A077699-001 | MEFLOQUINE HYDROCHLORIDE | 250MG | TABLET / ORAL | 2010-04-21 | cb3db0bc1861… | ||
| 2026-07-26 02:55 UTC · 3 captures of this ZIP | 2026-06 | A077699-001 | MEFLOQUINE HYDROCHLORIDE | 250MG | TABLET / ORAL | 2010-04-21 | a50c72e98297… |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Mefloquine Hydrochloride | MEFLOQUINE HYDROCHLORIDE | Teva Pharmaceuticals USA, Inc. | 09716a24-d7da-42b2-af29-c03a1b6670bd | 2025-09-26 | Boxed warning, Warnings, Adverse reactions | Mefloquine Hydrochloride MEFLOQUINE HYDROCHLORIDE |
| Mefloquine Hydrochloride | MEFLOQUINE HYDROCHLORIDE | A-S Medication Solutions | 9cbe26c7-7313-4cd6-9514-9190af1de763 | 2025-04-03 | Boxed warning, Warnings, Adverse reactions | Mefloquine Hydrochloride MEFLOQUINE HYDROCHLORIDE |
| Mefloquine Hydrochloride | MEFLOQUINE HYDROCHLORIDE | Chartwell RX, LLC | b884d22b-aae7-4f14-9a04-ae4029a229f0 | 2024-11-18 | Boxed warning, Warnings, Adverse reactions | Mefloquine Hydrochloride MEFLOQUINE HYDROCHLORIDE |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.
NDC Listings For This Application#
| NDC | Name | Nonproprietary name | Labeler | Marketing category | Status |
|---|---|---|---|---|---|
| 0143-1282 | Mefloquine Hydrochloride | Mefloquine Hydrochloride | West-Ward Pharmaceuticals Corp | ANDA | Current |
| 21695-561 | Mefloquine Hydrochloride | Mefloquine Hydrochloride | Rebel Distributors Corp | ANDA | Current |
| 52959-803 | Mefloquine Hydrochloride | Mefloquine Hydrochloride | H.J. Harkins Company, Inc. | ANDA | Current |